Search the LJMU website

1. "I'm so proud I could burst"

   LJMU named 'Nurse Education Provider of Year'

2. Graduation review Thursday 11 July 2019

   The penultimate day of our summer graduation week boasted three ceremonies; graduands from Liverpool Business School celebrated in both the morning and afternoon, while graduands from the School of Humanities and Social Science enjoyed their ceremony with family and friends from 5pm.

3. Olympus partnership to train more professionals in cancer screening

   Liverpool John Moores University is set to train more people in diagnosing cancer thanks to a partnership with global optics firm Olympus.

4. Join an LJMU Staff Network and take on a key Network Official role

   Did you know LJMU has a number of Equality, Diversity and Inclusion (EDI) related Staff Networks and Ally Groups, that LJMU and JMSU staff can join?

5. Sport science students make an impact with nearly 15,000 hours of placements

   From community sports clubs that support people with special educational needs to premier league football clubs, 173 students have undertaken 14,730 hours of work-based placements this academic year.

6. Celebrating Women Academics At LJMU

   LJMU's Equality, Diversity and Inclusion (EDI) Team reached out to a number of inspirational women-academics across the institution and asked them to share their personal journeys...here is what they had to say.

7. Bronze for three schools as Athena Swan push accelerates

   Congratulations to the School of Pharmacy and Biomolecular Sciences, the Liverpool Business School and the Astrophysics Research Institute on achieving the Athena SWAN Charter Mark.

8. Milky Way research earns Parliament invite

   Early-career researcher Hannah Dalgleish was invited to Parliament after making a new discovery about the Milky Way.

9. 'Black children often alienated in early years education'

   Education professional Diane Garrison starts conversation about depth of school 'othering'

10. Go ahead for new treatment for Black Bone Disease

    A new drug to treat the ultra-rare genetic disease alkaptonuria (AKU) has been given the go-ahead following research in Liverpool.